U.S. Food and Drug Administration
U.S. Food and Drug Administration Articles
Americans generally would like to spend less money on health care. One way that this can be and will be accomplished is through the continued use and expanded use of generic drugs.
Published:
Last Updated:
The biggest bit of marijuana industry news in the week ending August 12 was that the DEA rejected a call to loosen federal restrictions on marijuana.
Published:
Last Updated:
AcelRx Pharmaceuticals announced an update on the timing and potential content of its resubmission of the New Drug Application (NDA) for Zalviso.
Published:
ThinkstockOncolytics Biotech Inc. (NASDAQ: ONCY) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug designation for Reolysin. Reolysin is the company’s lead product...
Published:
Last Updated:
GW Pharmaceuticals reported top-line results from the first of three Phase 3 trials for Sativex.
Published:
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
Published:
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.
Published:
Array BioPharma has announced that it had reached a definitive agreement with Novartis to regain full worldwide rights to cancer drug binimetinib.
Published:
Avanir Pharmaceuticals announced that it has entered into a definitive agreement with Otsuka Pharmaceutical for a $17.00 per share buyout.
Published:
U.S. Food & Drug AdministrationA purported herbal sexual health supplement called O.M.G. has been found by the U.S. Food and Drug Administration (FDA) to contain generic sildenafil, the...
Published:
Last Updated:
After markets closed last Friday, MannKind announced that the FDA had approved Afrezza, a rapid-acting, inhaled insulin powder that improves glycemic control in adults with diabetes.
Published:
Last Updated:
ThinkstockThe U.S. Food and Drug Administration (FDA) late Friday afternoon announced that it has approved Afrezza, a rapid-acting, inhaled insulin power that improves glycemic control in adults with...
Published:
Last Updated:
Shares of Sarepta Therapeutics went through the roof Monday morning following an announcement that it plans to have a New Drug Application filed with the FDA by the end of 2014 for its muscular...
Published:
Last Updated:
Usually when you see stocks double, it is based on a buyout or a major partnership development. That is not the case for Furiex Pharmaceuticals, which soared on news of positive top-line study...
Published:
Chelsea Therapeutics International is on the leader board for percentage gains on Thursday, with a rise of 111% or so. And it isn't even on news of a buyout. Can the company live up to its potential?
Published: